Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer-Reference-Cited by-同舟云学术

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

Published:2009-06-13 Issue:3 Volume:27 Page:571-577
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Al-Tweigeri Taher A.,Ajarim Dahish S.,Alsayed Adher A.,Rahal Mohamed M.,Alshabanah Mohamed O.,Tulbah Asma M.,Al-Malik Osama A.,Fatani Doha M.,El-Husseiny Gamal A.,Elkum Naser B.,Ezzat Adnan A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-009-9251-7.pdf

Reference35 articles.

1. Schwartsmann G. Breast cancer in South America: challenges to improve early detection and management of a public health problem. J Clin Oncol. 2001;19(Suppl 18):118S–24S.

2. Chopra R. The Indian scene. J Clin Oncol. 2001;19(18):106S–111S.

3. Adebamowo CA, Adekunie OO. Case controlled study of the epidemiological risk factors for breast cancer in Nigeria. Br J Surg. 1999;86:665–8.

4. Devi B, Tang T, Corbex M. Reduction by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical down staging in Sarawak, Malaysia. Ann Oncol. 2007;18:1172–6.

5. Kaufmann M, Von Minckwitz G, Smith R, et al. International expert panel on the use of primary systemic of operable breast cancer: review and recommendations. J Clin Oncol. 2003;21:2600–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer;Journal of Oncology;2021-02-12

2. Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis;Clinical Cancer Research;2020-02-11

3. Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study;Oncotarget;2017-05-17

4. A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer;Cancer Chemotherapy and Pharmacology;2015-11-12

5. Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer;Reviews on Recent Clinical Trials;2015-07-14